1-4 of 4
Cédric Leroy
Close
Sort by
Journal Articles

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

Romain Gioia, Cédric Leroy, Claire Drullion, Valérie Lagarde, Gabriel Etienne, Stéphanie Dulucq, Eric Lippert, Serge Roche, François-Xavier Mahon, Jean-Max Pasquet
Journal: Blood
Blood (2011) 118 (8): 2211–2221.
https://doi.org/10.1182/blood-2010-10-313692
Published: 2011
Includes: Supplemental data
Journal Articles

Quantitative Phosphoproteomics Identified a New Syk-Lyn-Axl Signalling Pathway Involved In Resistance to Nilotinib In Chronic Myeloid Leukemia Cells.

Romain Gioia, Ph, D, Cedric Leroy, Ph, D, Claire Drullion, Valérie Lagarde, Serge Roche, Ph, D, Francois-Xavier Mahon, MD, PhD, jean-Max Pasquet, Ph, D
Journal: Blood
Blood (2010) 116 (21): 3376.
https://doi.org/10.1182/blood.V116.21.3376.3376
Published: 2010
Journal Articles

Tyrosine Kinase Proteins profiling of Nilotinib Resistant Chronic Myelogenous Leukemia Cells Unravels a Tyrosine Kinase-Mediated Bypass.

Jean-Max Pasquet, Romain Gioia, Claire Drullion, Valerie Lagarde, Cedric Leroy, Serge Roche, Bruno Cardinaud, Francois-Xavier Mahon
Journal: Blood
Blood (2009) 114 (22): 2175.
https://doi.org/10.1182/blood.V114.22.2175.2175
Published: 2009
Journal Articles

Lyn Kinase Overexpression Is One of the Mechanisms of Resistance to Nilotinib In Chronic Myeloid Leukemia

Francois-Xavi er Mahon, Sandrine Hayette, Valerie Lagarde, Franck E Nicolini, MD, PhD, Francis Belloc, Cedric Leroy, Serge Roche, Paul Manley, PhD, Coralie Belanger, Gabriel Etienne, Jean-Max Pasquet
Journal: Blood
Blood (2008) 112 (11): 3181.
https://doi.org/10.1182/blood.V112.11.3181.3181
Published: 2008